How many insider declarations has Liu Ye filed?

Liu Ye has filed 4 public insider declarations with SEC (Form 4).

What is Liu Ye's role?

Liu Ye's reported role is not specified by the regulator across the filings.

Which companies does Liu Ye report trades for?

Liu Ye reports trades for 2 companies, including EyePoint Pharmaceuticals, Inc..

What is Liu Ye's declared buy vs sell volume?

Across the available history, declared buys total 0 and disposals 47.3M€.

← Executives ★ Sign in to follow

LY

Liu Ye

·SEC (Form 4)

EyePoint Pharmaceuticals, Inc.Ocumension Therapeutics - B

累计流向

0

申报总数

0

公司

—

▲ 买入（0 笔）

€4734万

▼ 卖出（3 笔）

内部人交易记录

其他

已披露买入

0

已披露卖出

3

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

Explore the detailed record of transactions filed by Liu Ye. Officer active across 2 companies, notably EyePoint Pharmaceuticals, Inc.. Cumulatively, 4 reports have been published. Breakdown: 0 buy · 3 sells. Total volume traded: €47.3m. Activity tracked since 30 May 2023. The latest transaction was disclosed on 11 January 2024 (Cession). Regulator: SEC (Form 4). The full history is openly available.

Companies and markets linked to Liu Ye

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

EyePoint Pharmaceuticals, Inc. (US)Ocumension Therapeutics - B (HK)

申报4 总计

●

Liu Ye

Director高管2026年6月26日Ocumension Therapeutics - B

0HKEX ↗

203,459 股ShareXHKGHKEX:DA20260702E00732

▼

Liu Ye

Director高管2024年1月11日EyePoint Pharmaceuticals, Inc.

US$3716万33SEC ↗

1,910,500 股@ US$19.4571.5% 占其流量Common Stock, $0.001 par valueSEC:0001562180-24-000466:0

▼

Liu Ye

Director高管2023年12月5日EyePoint Pharmaceuticals, Inc.

US$1461万29SEC ↗

733,758 股@ US$19.9128.5% 占其流量Common Stock, $0.001 par valueSEC:0001562180-23-008222:0

▼

Liu Ye

Director高管2023年5月30日EyePoint Pharmaceuticals, Inc.

US$611SEC ↗

1 股@ US$6.000.0% 占其流量Common Stock, $0.001 par valueSEC:0001562180-23-004632:0

4 条申报中的 4 条

InsidersTradesSigma

← Executives ★ Sign in to follow

LY

Liu Ye

·SEC (Form 4)

EyePoint Pharmaceuticals, Inc.Ocumension Therapeutics - B

累计流向

0

申报总数

0

公司

—

▲ 买入（0 笔）

€4734万

▼ 卖出（3 笔）

内部人交易记录

其他

已披露买入

0

已披露卖出

3

尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。

信号历史

Explore the detailed record of transactions filed by Liu Ye. Officer active across 2 companies, notably EyePoint Pharmaceuticals, Inc.. Cumulatively, 4 reports have been published. Breakdown: 0 buy · 3 sells. Total volume traded: €47.3m. Activity tracked since 30 May 2023. The latest transaction was disclosed on 11 January 2024 (Cession). Regulator: SEC (Form 4). The full history is openly available.